CPA Letter to USTR Tai on Section 301 Tariff Exclusions
CPA sent the following the letter urging U.S. Trade Representative Katherine Tai to not expand exclusions to Chinese imports subject to Section 301 tariffs. Dear
Details
Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman
CPA’s report, titled “Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman,” details how a loophole
Tariff Incidence in the Real World: Why Consumers (Mostly) Didn’t Pay the Steel Tariffs
Summary points: The import price of steel fell in the period following the 2018 imposition of a 25% steel tariff, an indicator that steel tariffs
New CPA Report Documents How Hatch-Waxman Act Loophole Led to Offshoring of Generics Production, Price Gouging, and Shortages
WASHINGTON — The Coalition for a Prosperous America (CPA) today released a new academic report that details how a loophole in the Hatch-Waxman Act has
China Tech & Industry Official Wants U.S. as Clean Tech, Pharma Partner
A senior Chinese official told the U.S. China Business Council that the U.S. and China should partner on EVs and biotech. The private sector can do what it wants. But Washington should not take Beijing up on this offer.
CPA, Human Rights Organizations Urge Secretary Yellen to Use Capital Markets Sanctions Against Chinese Companies Aiding the CCP’s Campaign of Evil
WASHINGTON — The Coalition for a Prosperous America (CPA), along with human rights groups, urged Secretary of the Treasury Janet Yellen to protect American retail
Worker-Centered Trade Means Reshoring U.S. Industries
In June, U.S. Trade Representative Katherine Tai gave a speech in which she outlined her vision of worker-centered trade, a popular phrase among Biden administration
CPA Letter to Treasury Secretary Janet Yellen Regarding Capital Markets Sanctions Against Chinese Companies
CPA, along with human rights groups, sent the following letter to Secretary of the Treasury Janet Yellen urging her to protect American retail investors and
Tainted Blood Pressure Medication from India Can ‘Change Someone’s DNA’
An Indian drug market that’s been the subject of FDA warnings since 2017 is the apparent source of tainted medication sold in the U.S. and Canada. This is another example as to why we need to reshore critical supply of essential medication. Where is Congress?
CPA Members Zekelman Industries Funded Afghanistan Rescue of 534 U.S. Citizens
Task Force Argo’s latest $1.1 million evacuation mission in Afghanistan was largely funded by CPA member Zekelman Industries.
